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PCR” model and the “Endonucleolytic Cleavage” modelsiRNA: A Guide for RNA Silencing
(see Figure). The Random Degradative PCR model pro-
poses that siRNAs act as primers on the target mRNA,
akin to the primers used for PCR. This model is derived
RNAi is routinely used to eliminate gene activity for from time course studies [10] by Paterson’s group that
experimental purposes. However, the precise molecu- show that 32P-labeled siRNAs bind to their complemen-
lar mechanism of RNAi is unknown. Recent papers tary target mRNA and are extended by nucleotide addi-
partially illuminate this mechanism in human cells, ad- tion in a target-dependent manner, ultimately converting
vancing the potential application of RNAi toward the the single-stranded target mRNA to dsRNA (see Figure,
treatment of human disease. panel B). As this reaction continues, the dsRNA is frag-
mented, eliminating the target RNA and generating new
RNA interference (RNAi) is a form of posttranscriptional siRNAs. This Degradative model requires both RNA-
control in which the introduction of a double-stranded dependent RNA polymerase (RdRP) and Dicer to explain
RNA (dsRNA) into a cell leads to specific degradation the observation of siRNA-mediated target destruction.
of mRNAs with complementary sequence. RNAi was In support of this, single-stranded antisense RNAs rang-
first discovered in C. elegans but has subsequently been ing from 19 to 40 nucleotides have been found to be
found in other animal species, including Drosophila and effective in germline RNA silencing in C. elegans [11].
humans. Mechanisms of posttranscriptional control Such silencing is dependent on a 3-OH group and Dicer,
similar to RNAi also exist in plants and are known as indicating both RdRP and Dicer are involved in RNA
PTGS (posttranscriptional gene silencing) and cosup- silencing [11]. Indeed, mutation of RdRP leads to the
pression, and in fungi (quelling) [1]. The natural function abolition of posttranscriptional gene silencing in plants
of RNAi is thought to be a primitive immune response [12], quelling in N. crassa [13], and RNAi in C. elegans
against parasitization by foreign nucleic acids, such as [14]. The involvement of RdRP in the Degradative model
RNAs from viral pathogens, and rapid spreading of of siRNA function could also explain the requirement
transposons and retroposons. The RNAi molecular ma- for the presence of a 3-OH group on siRNA [10], as well
chinery is also partially involved in the generation of as the observation in C. elegans of “transitive RNAi,”
single-stranded micro-RNAs (miRNAs), some of which which is the spread of the effect of RNA silencing origi-
are involved in developmental patterning [2, 3]. nating from the 3 end of the target mRNA toward 5
Since its discovery in C. elegans, RNAi has been de- end [15].
veloped as an important tool for reverse genetics. RNAi The Endonucleolytic Cleavage model hypothesizes
is now being used routinely to knock down gene function that siRNAs act as guides for proteins to cleave the
in molecular genetic dissections of biological processes target mRNA [16]. In this case, the siRNAs combine with
[1]. The existence of RNAi in human cells, and the devel- proteins to form a riboncleoprotein complex called RISC
opment of RNAi in cell cultures, suggests the intriguing (RNA-induced silencing complex). Upon activation with
possibility that this procedure could be developed as a ATP, siRNAs are unwound and guide activated RISC
powerful tool for gene therapy in humans [4]. However, (RISC*) to cleave the target. This model is supported
despite the widespread use of RNAi as a tool in biologi- by many in vitro studies. Zamore’s group showed that
cal research, the molecular mechanism of RNAi is not cleavage of the target mRNA in Drosophila extracts is
understood. Although many of the factors involved in seen only in the region exactly complementary to the
RNAi have been identified through mutation studies or to input siRNA and does not spread to the 5 end of the
by biochemical purification, the roles of many of these target mRNA [16, 6]. In addition, functional studies of
factors remain unclear, and although RNAi and similar siRNA in Drosophila lysates have demonstrated that
phenomena such as PTGS, cosuppression, and quelling each siRNA duplex cleaves its target RNA at single site
share common features, it is not known if they use an [17]. Further, Zamore’s group showed that RISC is
identical mechanism. turned over multiple times, presenting evidence for its
In vitro studies have defined the initial steps of RNA catalytic nature [18]. This model does not invoke the
interference: double-stranded RNA is converted to involvement of RdRP activity in siRNA-mediated si-
21–23 double-stranded nucleotide fragments, called lencing.
small interfering RNAs (siRNAs), by the RNaseIII enzyme, The Degradative PCR model predicts a compulsory
Dicer [5, 6]. Such RNAs have also been observed in requirement of a 3-OH group on guide/antisense strand
plants undergoing posttranscriptional gene silencing or of siRNA to allow for RdRP activity. Recently published
cosuppression [7]. The mechanism by which these siRNAs studies provide evidence that blocking the 3 end of
mediate the cleavage and destruction of RNA is being the guide strand with either 23dideoxy cytidine, amino
actively investigated by several groups. Recent papers modifier [8], puromycin, or biotin [9, 19] does not inhibit
from the Zamore [8] and Rana groups [9] make signifi- siRNA action either in vivo or in vitro in Drosophila and
cant advances in shedding light on the mechanism of human systems. Therefore, siRNA extension by RdRP
siRNA-mediated RNA silencing in human cells. does not appear to be a necessary step in siRNA-medi-
Two competing models of siRNA function have been ated cleavage/silencing in these systems, despite the
clear evidence for such an RdRP activity in Drosophilapresented in the literature: the “Random Degradative
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Schematic Representation of RNAi Pathway Derived from Drosophila Extracts
There is consensus regarding the initiation step of RNAi, i.e., that Dicer converts longer dsRNA into 21–23 nt ds siRNA fragments. However,
it remains unclear as to how siRNAs mediate the cleavage of target mRNA.
(A) The endonucleolytic cleavage model proposes that siRNAs act as guides. siRNAs form a precursor protein complex called RNA-induced
silencing complex (RISC). Upon ATP activation, it unwinds the siRNAs and converts into an activated RISC (RISC*). RISC* recognizes the
target and cleaves it with an endonuclease.
(B) In contrast, the random degradative PCR model proposes that siRNAs act as primers on the target mRNA and are extended by RdRP to
produce dsRNA (cRNA/target RNA hybrid). The ds cRNA/target RNA hybrid is degraded by Dicer. There is a strict requirement of RdRP and
Dicer in this model.
extracts. Since a canonical RdRP homolog has not been the Degradative Model to work, Dicer would have to be
extremely efficient to avoid steady-state accumulationfound in either the Drosophila or human genomes, a
noncanonical RdRP may perform this function. How- of dsRNA. In C. elegans, on the other hand, the Degrada-
tive Model of siRNA function could be tolerated, as theever, there is a strict requirement of 5-phosphate group
on the guide strand of the siRNA. A requirement for 5- presence of dsRNA is known to result in specific RNA
interference rather than general translation inhibition. Itphosphorylation of siRNAs is observed both in Drosoph-
ila and human lysates in vitro [8] and human cell in vivo is interesting that both the Degradative and Endonucleo-
lytic models are derived from experiments in Drosophila[9]. Another characteristic of the Degradative model is
that Dicer must acts twice in the pathway to eliminate embryo extracts. In this system, initial experiments [10]
showed that siRNA priming and extension occurred, butthe mRNA (see Figure). However, Tuschl and colleagues
[19] have shown that immunodepletion of Dicer from in other work [16] it was reported that siRNA leads to
cleavage of a target only at one site. How can one recon-human extracts does not inhibit siRNA mediated cleav-
age. Also, partial purification of RNA-induced silencing cile such disparate results? Perhaps RdRP activity is
not active in the extracts prepared from Zamore andcomplex from human cells or Drosophila cells does not
contain Dicer [19]. These results do not support the idea Tuschl’s group, or the enzyme has been inadvertently
activated in Drosophila extracts prepared by Paterson’sthat siRNA-mediated cleavage is dependent on Dicer;
however, it has not been determined whether com- group. These conflicting observations could be clarified
in part if an RdRP activity could be purified from Dro-pletely eliminating Dicer function in vivo by gene knock-
out has an effect on siRNA-mediated RNAi in insect and sophila or human cells.
An important result which has emerged from recentmammalian cells.
It is tempting to speculate that in human cells, RNAi studies is that single-stranded antisense RNA can also
enter the RNAi pathway, albeit less efficiently, than thedoes not function via the Degradative Model because
the accumulation of long double-stranded RNA would ds siRNA [19, 8]. Since a 3-OH group is not a compul-
sory requirement for RNAi in human cells, transitive RNAiactivate the interferon response pathway, resulting in
general inhibition of translation [20], rather than specific is not likely to be operating here. These new results
from studies of human and insect cells encourage andposttranscriptional interference of a gene. Therefore, for
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NikR by loading the protein on a Ni-nitrilotriacetate (NTA)
affinity column: a common expedient used for the affinity
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Sensing Nickel:
NikRs with Two Pockets purification of proteins bearing histidine repeats (His-
tagged proteins). Unexpectedly, NikR stripped Ni(II)
away from NTA and therefore failed to bind the column.
Their subsequent studies revealed two Ni(II) bindingNikR represses expression of a nickel transporter in
sites per NikR monomer: the high-affinity site detected inresponse to elevated levels of Ni(II). Recent results
the metal-chelate chromatography and a second, muchsuggest that repression is elicited by binding of nickel
weaker site (an estimated Kd 105 M). Repressor withto a high-affinity site, but a low-affinity binding pocket
Ni(II) bound to both sites interacts with operator DNAmay also play a role.
with exceptionally high affinity (a Kd of 15 pM) [4].
In the current study, Chivers and Sauer [1] character-Metal ions present a conundrum to the cell: they are
ize the interaction of Ni(II) with the high-affinity site (Kdessential for life, yet they can also be toxic when present
7 pM) in the carboxy-terminal domain of NikR, whichin excess. In recent years, considerable progress has
also contains determinants for tetramer formation. Oc-been made in defining the pathways by which cells ac-
cupancy of the high-affinity Ni(II) sites is sufficient forquire, distribute, store, and export metal ions. Metal ion
operator binding (Kd30 nM). This is a reasonably high-homeostasis typically involves one or more high-affinity
affinity interaction for a gene-specific regulatory protein,uptake pathways that are induced when metal ions are
but is 1000-fold weaker than the affinity exhibited whenlimiting and storage or efflux mechanisms induced when
both Ni(II) sites are occupied. Since both forms of NikRmetals are in surplus. Responsibility for regulating these
bind operator DNA, albeit with differences in affinity andopposing pathways rests with metalloregulatory pro-
extent of binding, it is natural to wonder which formteins that sense the intracellular levels of metal ions. In
mediates repression of the nickel transport operon inthis issue of Chemistry and Biology, Chivers and Sauer
vivo.report biochemical analyses of one such regulator, NikR,
To address this question, the authors have measuredthat has two distinct metal binding pockets: a high-
the intracellular concentration of active NikR as 125affinity and a low-affinity site [1].
tetramers per cell (200 nM). Since a single Ni(II) ion inNikR is a member of the ribbon-helix-helix family of
the cytosol represents a concentration of 1.6 nM, wellDNA binding proteins and represses Ni(II) transport
above the dissociation constant of the high-affinity site,when nickel levels in the cell are sufficient [2, 3]. Pre-
viously, Chivers and Sauer [4] attempted purification of NikR will serve as a high-affinity sink for Ni(II). The au-
